• Manage a team of individuals to source, develop, and maintain high value strategic partnerships with biopharma and academic partners• Negotiate and execute broad strategic partnerships with biopharma to map immune responses to cancer and infectious disease antigens to inform development of novel diagnostics and therapeutics• Build value-driven relationships focused on high-profile projects to meet yearly corporate goals (recognized revenue and new bookings)• Develop and launch new immunosequencing products (example: TMAP COVID) • Integrated the immunoSEQ research kit into academic core labs and CROs (2020-2022)• Developed ex-US business strategy to increase academic sales (2020)• Executed ex-US distributor agreements for the immunoSEQ kit (2020)

• Managed a team of 9 individuals to establish partnerships with biopharma and engage KOLs to drive portfolio innovation• Generated $XX million in recognized revenue through pharma partnerships, generated more than $XX million in new bookings, and initiated new partnerships with more than 30 biopharma companies.• Served as Alliance Manager for a broad Translational Partnership • Delivered customer and market insights to inform strategic product pipeline decisions

• Established and managed partnerships with top tier pharmaceutical companies and academic institutions • Established key collaborations with KOLs in various fields including autoimmunity, immuno-oncology, transplantation and hematology to validate new clinical applications for immunosequencing • Incorporated immunosequencing into pharma-sponsored clinical trials for patient stratification, biomarker discovery, and MRD detection• Initiated and executed contracts with pharmaceutical companies and key academic accounts • Led scientific communications - Lead organization of abstracts and posters for scientific meetings - Maintain publications database - Educate company about new customer publications• Assisted clients with experimental design and data interpretation